These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38991633)

  • 1. Levodopa-induced dyskinesia in Parkinson's disease: Insights from cross-cohort prognostic analysis using machine learning.
    Loo RTJ; Tsurkalenko O; Klucken J; Mangone G; Khoury F; Vidailhet M; Corvol JC; Krüger R; Glaab E;
    Parkinsonism Relat Disord; 2024 Sep; 126():107054. PubMed ID: 38991633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vision-based assessment of parkinsonism and levodopa-induced dyskinesia with pose estimation.
    Li MH; Mestre TA; Fox SH; Taati B
    J Neuroeng Rehabil; 2018 Nov; 15(1):97. PubMed ID: 30400914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levodopa-induced dyskinesia is preceded by increased levels of anxiety and motor impairment in Parkinson's disease patients.
    Dias CMV; Leal DAB; Brys I
    Int J Neurosci; 2023 Dec; 133(12):1319-1325. PubMed ID: 35603453
    [No Abstract]   [Full Text] [Related]  

  • 4. The relationship between the phenotype of Parkinson's disease and levodopa-induced dyskinesia.
    Zhang YH; Tang BS; Song CY; Xu Q; Lou MX; Liu ZH; Yu RH; Yan XX; Guo JF
    Neurosci Lett; 2013 Nov; 556():109-12. PubMed ID: 24135335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resting tremor in Parkinson disease: a negative predictor of levodopa-induced dyskinesia.
    Kipfer S; Stephan MA; Schüpbach WM; Ballinari P; Kaelin-Lang A
    Arch Neurol; 2011 Aug; 68(8):1037-9. PubMed ID: 21825240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profile of levodopa-induced dyskinesia in patients of Parkinson's disease: a record based study.
    Choudhury S; Pradhan R; Paul P; Das M; Gupta A; Ghosh P; Chatterjee S
    Neurol Res; 2014 Sep; 36(9):841-6. PubMed ID: 24601722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the Side Onset of Parkinson's Disease Influence the Time to Develop Levodopa-Induced Dyskinesia?
    Chung SJ; Yoo HS; Lee HS; Lee PH; Sohn YH
    J Parkinsons Dis; 2019; 9(1):241-247. PubMed ID: 30741690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presynaptic dopamine depletion predicts levodopa-induced dyskinesia in de novo Parkinson disease.
    Hong JY; Oh JS; Lee I; Sunwoo MK; Ham JH; Lee JE; Sohn YH; Kim JS; Lee PH
    Neurology; 2014 May; 82(18):1597-604. PubMed ID: 24719485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levodopa-induced dyskinesia is closely linked to progression of frontal dysfunction in PD.
    Yoo HS; Chung SJ; Lee YH; Lee HS; Ye BS; Sohn YH; Lee PH
    Neurology; 2019 Mar; 92(13):e1468-e1478. PubMed ID: 30796137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment patterns and associated costs with Parkinson's disease levodopa induced dyskinesia.
    Suh DC; Pahwa R; Mallya U
    J Neurol Sci; 2012 Aug; 319(1-2):24-31. PubMed ID: 22664154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levodopa-induced dyskinesia in Parkinson's disease: epidemiology, etiology, and treatment.
    Zesiewicz TA; Sullivan KL; Hauser RA
    Curr Neurol Neurosci Rep; 2007 Jul; 7(4):302-10. PubMed ID: 17618536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levodopa-Induced Dyskinesias are Frequent and Impact Quality of Life in Parkinson's Disease: A 5-Year Follow-Up Study.
    Santos-García D; de Deus T; Cores C; Feal Painceiras MJ; Íñiguez Alvarado MC; Samaniego LB; López Maside A; Jesús S; Cosgaya M; García Caldentey J; Caballol N; Legarda I; Hernández-Vara J; Cabo López I; López Manzanares L; González-Aramburu I; Ávila A; Gómez-Mayordomo V; Nogueira V; Dotor García-Soto J; Borrué-Fernández C; Solano B; Álvarez Sauco M; Vela L; Escalante S; Cubo E; Mendoza Z; Pareés I; Sánchez Alonso P; Alonso Losada MG; López-Ariztegui N; Gastón I; Kulisevsky J; Seijo M; Valero C; Alonso Redondo R; Buongiorno MT; Ordás C; Menéndez-González M; McAfee D; Martinez-Martin P; Mir P;
    Mov Disord Clin Pract; 2024 Jul; 11(7):830-849. PubMed ID: 38747234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l-DOPA treatment and changes in levodopa-induced dyskinesia.
    Andersen AD; Blaabjerg M; Binzer M; Kamal A; Thagesen H; Kjaer TW; Stenager E; Gramsbergen JBP
    J Neurochem; 2017 May; 141(4):614-625. PubMed ID: 28244186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebellar connectivity in Parkinson's disease with levodopa-induced dyskinesia.
    Yoo HS; Choi YH; Chung SJ; Lee YH; Ye BS; Sohn YH; Lee JM; Lee PH
    Ann Clin Transl Neurol; 2019 Nov; 6(11):2251-2260. PubMed ID: 31643140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex-specific association of urate and levodopa-induced dyskinesia in Parkinson's disease.
    Jung JH; Chung SJ; Yoo HS; Lee YH; Baik K; Ye BS; Sohn YH; Lee PH
    Eur J Neurol; 2020 Oct; 27(10):1948-1956. PubMed ID: 32441832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High levodopa plasma concentration after oral administration predicts levodopa-induced dyskinesia in Parkinson's disease.
    Shiraishi T; Nishikawa N; Mukai Y; Takahashi Y
    Parkinsonism Relat Disord; 2020 Jun; 75():80-84. PubMed ID: 32497995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine Pathway and Parkinson's Risk Variants Are Associated with Levodopa-Induced Dyskinesia.
    Sosero YL; Bandres-Ciga S; Ferwerda B; Tocino MTP; Belloso DR; Gómez-Garre P; Faouzi J; Taba P; Pavelka L; Marques TM; Gomes CPC; Kolodkin A; May P; Milanowski LM; Wszolek ZK; Uitti RJ; Heutink P; van Hilten JJ; Simon DK; Eberly S; Alvarez I; Krohn L; Yu E; Freeman K; Rudakou U; Ruskey JA; Asayesh F; Menéndez-Gonzàlez M; Pastor P; Ross OA; Krüger R; ; Corvol JC; Koks S; Mir P; De Bie RMA; Iwaki H; Gan-Or Z;
    Mov Disord; 2024 Oct; 39(10):1773-1783. PubMed ID: 39132902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levodopa-Induced Dyskinesia in Parkinson's Disease: Pathogenesis and Emerging Treatment Strategies.
    Kwon DK; Kwatra M; Wang J; Ko HS
    Cells; 2022 Nov; 11(23):. PubMed ID: 36496996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative assessment of levodopa-induced dyskinesia using automated motion sensing technology.
    Mera TO; Burack MA; Giuffrida JP
    Annu Int Conf IEEE Eng Med Biol Soc; 2012; 2012():154-7. PubMed ID: 23365855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of motor complications in early Parkinson's disease: A prospective cohort study.
    Kelly MJ; Lawton MA; Baig F; Ruffmann C; Barber TR; Lo C; Klein JC; Ben-Shlomo Y; Hu MT
    Mov Disord; 2019 Aug; 34(8):1174-1183. PubMed ID: 31283854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.